Showing results (411-420 of 415) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 415 results.
The Lancet. Haematology|November 26, 2021
Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trialJacob D Soumerai, Anthony R Mato, Ahmet Dogan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)A Younes, P Hilden, B Coiffier, et al.
Blood|January 9, 2019
Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphomaBruno M Grande, Daniela S Gerhard, Aixiang Jiang, et al.
Blood Advances|June 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKsJacob D Soumerai, Meghan C Thompson, Ahmet Dogan, et al.
Blood|October 6, 2022
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphomaNicole Thomas, Kostiantyn Dreval, Daniela S Gerhard, et al.
Pageof 42